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ABSTRACT. Objective. The aim of this study was to validate
the V-Sign digital sensor (SenTec AG, Therweil, Switzerland)
for combined noninvasive assessment of pulse oxymetric oxygen
saturation (SpO2) and transcutaneous carbon dioxide tension
(PtcCO2) in adults after cardiac surgery. Methods. In twenty
one patients, aged 51–86 years, simultaneous measurements of
blood gases with the V-Sign Sensor and with two Nellcor
Durasensors (model DS-100A), one at the opposite earlobe and
one with a finger clip, were compared first during hyper-,
normo- and hypocapnia and at different pulse rates using a
pacemaker, and then at 2-h intervals up to 8 h. Agreement was
assessed by Bland-Altman analysis. Results. PtcCO2 data of
three patients were excluded because of calibration failure of the
device. Median (range) PtcCO2 for the remaining patients was
5.49 (3.3–7.6) kPa and arterial carbon dioxide tension (PaCO2)
was 5.43 (3.61–7.41) kPa. Corresponding mean bias was
+0.05 kPa and limits of agreement (LOA) were )1.2/
+1.3 kPa. During normo- and hypoventilation, mean bias was
good at +0.02 and +0.04 kPa respectively, but limits of
agreement were poor at )0.67/+0.69 and )0.81/+0.88 kPa.
In 10 patients, an initial overshoot of PtcCO2 was observed.
Mean bias of SpO2 and pulse rate was close to zero ()1.5% and
+0.001 bpm respectively), but limits of agreement were
unacceptably high ()21.4/+18.4% and )22.3/
+22.3 bpm). Conclusions. In the present state of
development the SenTeC Digital monitor V-Sign device has
serious limitations. Additional efforts are necessary to eliminate
calibration failures and the initial overshoot of PtcCO2 as well as
to improve detection of SpO2 and pulse rate.
KEY WORDS. combined transcutaneous PCO2 and SpO2, digital
ear sensor, cardiac surgery intensive care unit.
ABBREVIATIONS
bt blood temperature
CI cardiac index
ICU intensive care unit
N395-ECG pulse rate measured by Nellcor N-395 using
an ear-lobe senor
N395-SpO2 partial oxygen saturation measured by
Nellcor N-395 using an ear-lobe sensor
N595-ECG pulse rate measured by Nellcor N-595, using
a finger clip
N595-SpO2 partial oxygen saturation measured by
Nellcor N-595 using a finger clip
PaO2 arterial oxygen tension
PaCO2 arterial carbon dioxide tension
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pCO2 partial carbon dioxide tension
PECO2 endtidal carbon dioxide partial pressure
PR pulse rate
SaO2 arterial oxygen saturation
SDM-PR SenTec Digital Monitor pulse rate
SDM-SpO2 SenTec Digital Monitor pulse oximetry
oxygen saturation
SpO2 pulse oximetry oxygen saturation
TcPCO2 transcutaneous partial carbon dioxide ten-
sion
TOSCA TOSCA monitor, Linde Medical Sensors,
Basel Switzerland for combined measure-
ment of transcutaneous partial carbon diox-
ide tension, pulse oximetry oxygen
saturation
V-SignTM V-Sign
TM ear-lobe sensor (SenTec Digital
Monitor System (SDM))
INTRODUCTION
Continuous non-invasive monitoring of respiratory
parameters is desirable under a variety of circumstances.
The use of oxygen saturation as measured by pulse
oximetry (SpO2) and capnometric assessment of end-tidal
carbon dioxide partial pressure (PECO2) is standard
practice for non-invasive monitoring of oxygenation and
ventilation during anaesthesia. However, during cardio-
thoracic or laparoscopic surgery and in patients with
pulmonary disease, PECO2 is not always accurate [1–4].
In spontaneously breathing patients, correct assessment of
PECO2 is difficult [5]. Acute changes in ventilation are
first reflected by changes in partial pressure of CO2
(PCO2), whereas the change in oxygenation detected by
SpO2, is delayed. In newborns and infants, transcutaneous
measurement of carbon dioxide partial pressure (PtcCO2)
was introduced 20 years ago [6–8] for noninvasive con-
tinuous monitoring of ventilation. However, sensor
preparation, positioning, taping, and the necessity for re-
peated changes of the sensors location made handling
difficult and complicated its use [9]. More recently, two
new devices, the SenTec Digital Monitor V-sign sensor
and the TOSCA devise, for combined assessment of
PtcCO2 and SpO2 using a single ear-clip sensor were
introduced [9–12]. To the best of our knowledge, only
three studies assessing the accuracy and reliability of the
V-Sign sensor (V-Sign Sensor, SenTec Digital Monitor-
ing System: SenTec AG, Therwil, Switzerland) have so far
been published: one in adult volunteers [11], one in
patients during bronchoscopy [12], and one in critically ill
patients in a medical intensive care unit (ICU) [13]. The
V-Sign sensor measures PtcCO2, pulse rate and SpO2
continuously and noninvasively. It combines the elements
of a Stow-Severinghaus-type PCO2 sensor and a con-
ventional pulse oximetry sensor. The sensor temperature
is heated up to 42C to achieve local arterialization of the
skin at the site for PtcCO2 monitoring. Prior to the
application of the sensor to the patients ear, an automatic
calibration of the sensor is performed in vitro. Afterwards,
the sensor is mounted at the ear lobe, and the first mea-
surement is done after allowing a 20-min equilibration
time. Until now, no data were available regarding the
accuracy and reliability of this device in critically ill adult
patients after cardiac surgery
The aims of this study were (i) to validate the data
acquired with the V-Sign sensor in comparison with
arterial carbon dioxide tension (PaCO2), arterial oxygen
saturation (SaO2), and pulse rate derived from the elec-
trocardiography under various clinical conditions in pa-
tients early after cardiac surgery, (ii) to assess the
agreement of SpO2 and pulse rate with corresponding data
monitored with standard ear-clip and finger-clip pulse
oximetry devices, and (iii) to investigate the safety and
feasibility of the V-Sign device.
METHODS AND MATERIALS
With ethics committee approval and written informed
consent, 21 patients scheduled for elective cardiac surgery
were enrolled in this prospective single-center trial.
Exclusion criteria were non-German-speaking patients,
unstable haemodynamics, arrhythmias, and age <18 years.
Criteria for ending a subjects participation were unstable
haemodynamics and/or significant arrhythmias, need for
re-operation, a serious skin lesion at the earlobe and
withdrawal of consent by the patient or relatives. Before
the surgery, standard instrumentation included a 2-chan-
nel ECG (leads II and V5) (Hellige SMU 612 monitor,
Marquette-Hellige, Freiburg i.Br, Germany), continuous
arterial blood pressure monitoring via a fluid-filled cath-
eter system (Baxter Healthcare Corp. Cardiovascular
Group Irvine) connected to the nondominant radial ar-
tery, a triple-lumen central venous catheter (Arrow
International, Reading, PA) and a 7.5-FG thermistor-
tipped, flow-directed pulmonary artery catheter (Intelli-
Cath Baxter Healthcare Corporation Edwards Critical
Care Division), introduced through an 8.5-FG introducer
(Arrow International) inserted in the right internal jugular
vein and connected to a cardiac output computer system
(9520A Baxter Healthcare Corporation).
According to institutional policy, all patients were
instrumented with right atrial and right ventricular epi-
cardial pacemaker wires before chest closing. After arrival
of the patient in the ICU, three pulse oximeter sensors
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were attached according to the manufacturers directions.
For noninvasive, continuous recording of SpO2, PtcCO2
and pulse rate, the V-Sign sensor was attached to the
inside of the left ear lobe using an adhesive Ear-Clip, and
connected to the SenTec Digital Monitor. A second
sensor for noninvasive, continuous recording of SpO2
(Nellcor Durasensor model DS-100A) was attached to the
inside of the right earlobe and connected to a Nellcor
N-395 pulse oximeter (Nellcor Puritan Bennet Inc.,
Pleasanton, CA). Another Nellcor Durasensor (model
DS-100A) was attached by finger clip and connected to a
Nellcor N-595 pulse oximeter. Data were computed for
subsequent plotting and statistical analysis. Arterial blood
samples were drawn from the indwelling arterial catheter
at time points specified in the study protocol (see below).
PaCO2 was measured at a standard temperature of
37C, and SaO2 was determined by direct oximetry
(multi-wavelength hemoximetry) (ABL 625/620, Radi-
ometer Medical A/S, Akandevej 21 DK-2700 Bronshoj,
Denmark).
All data detected by the V-sign sensor, and by the ear-
clip and finger-clip sensors of the Nellcor devices were
automatically collected online by a computing system.
The time points of the arterial samples and the results of
the corresponding blood gas and haemoximetry values
were also recorded.
At the time points of the arterial blood samples, all data
were documented on a separate protocol sheet. Additional
recordings included PECO2, mean arterial pressure, car-
diac index, blood temperature, peripheral skin perfusion
(I = warm and dry; II = cool; III = cold) and skin status
at the earlobe where the V-sign sensor was attached
(0 = no reddening; 1 = slight reddening; 2 = reddening;
3 = intensive reddening; 4 = blister). After haemody-
namic stabilization in the ICU, arterial blood samples (BS)
were taken before attaching the sensors (BS1), 7.5 min
(BS2) and 15 min (BS3) after attaching the sensors (cali-
bration procedure); two samples were taken with an
interval of 5 min after 20 min of hyperventilation (target
PaCO2 = 4.5 kPa) (BS4 and BS5); two samples were
taken with an interval of 5 min after 20 min of normo-
ventilation (target PaCO2 = 5.0 kPa) (BS6 and BS7), two
samples were taken with an interval of 5 min after 20 min
of hypoventilation (target PaCO2 = 6.5 kPa) (BS8 and
BS9), and two samples were taken with an interval of
5 min after 2, 4, 6 and 8 h after starting the trial (BS10-
BS17). To investigate the accuracy of the V-Sign device
to detect pulse rate, we varied the heart rate, each for a
duration of 30 s, from 60 to 90 to 120 bpm, using an
external temporary pacemaker during the period between
the blood samples BS9 and BS10. Before starting the trial
and after 2, 4, 6, 8 and 14 h, the skin status at the earlobe
was documented.
The power calculation revealed that 20 patients were
necessary to estimate variation between and within sub-
jects with an accuracy of at least 15%. Bland-Altman
analysis [14] was applied to assess mean bias and limits of
agreement (LOA) (±2 SD of bias) of PaCO2 and PtcCO2,
SaO2 and corresponding values of V-Sign SpO2, Nellcor
N-395 SpO2 and Nellcor N-595 SpO2 as well as pulse
rate derived from the ECG, V-Sign, Nellcor N-395 and
Nellcor N-595. Multiple regression analysis was per-
formed to assess whether blood temperature, pulse rate,
cardiac index, skin status and mean arterial pressure sig-
nificantly influenced PtcCO2, PaCO2 and the difference
between PtcCO2 and PaCO2 (PtcCO2–PaCO2). In
addition, linear regression analysis was performed to assess
first differences in transcutaneous and arterial PCO2.
RESULTS
About 21 patients were enrolled; their characteristics and
cardiorespiratory parameters are listed in Table 1. PtcCO2
values for 3 patients were excluded because of calibration
failure of the V-Sign device. In the remaining 18 patients,
273 data pairs of PtcCO2 and PaCO2 were available for
analysis. Median (range) PtcCO2 and PaCO2 were 5.49
(3.3–7.6) and 5.43 (3.61–7.41) kPa, respectively. Corre-
sponding mean bias was +0.05 kPa and LOA were )1.2/
+1.3 kPa (Figure 1, Table 2). In 10 patients, PtcCO2
showed an initial overshoot until 8–25 min following
calibration of the system (Figure 2). At the 2- to 8-h
sample times, PtcCO2 showed a drift toward lower values
when compared with PaCO2 in 15 patients (Figure 2).
No correlation was found between PtcCO2 and PaCO2
with blood temperature, pulse rate, cardiac index, skin
status or mean arterial pressure, whereas the difference
between PtcCO2 and PaCO2 significantly decreased with
increasing blood temperature (p < 0.0001). PECO2 cor-
Table 1. Patients characteristics and hemodynamic dataa
No. of Patients 21
Age, year 69 ± 8.8 (51–86)
Male/female 16/5
BMI, kg/m2 28.6 ± 4.7 (21.5–38.3)
Type of surgery
CABG 11
Valve 5
Combined 5
Cardiac index, liter/min/m2 2.66 ± 0.59 (1.53–5.18)
Mean arterial pressure, mmHg 72 ± 9 (49–105)
aValues are expressed as mean ± SD (range).Abbreviations: BMI,
body mass index; CABG, coronary artery bypass graft.
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related well with PaCO2 (r
2 = 0.58; p < 0.001), but only
moderately with PtcCO2 (r
2 = 0.22; p < 0.0001). Median
and range of carbon dioxide tension during various
respiratory conditions are listed in Table 2. During the
periods of normo- and hypoventilation, PtcCO2 values
showed a satisfactory agreement with PaCO2; agreement
was less during hyperventilation (Table 3). First differ-
ences of PtcCO2 and PaCO2 showed only moderate
correlation (Figure 3) with sensitivity of 82.9% and
specificity of 54%.
Mean bias between V-Sign SpO2 and SaO2, and be-
tween V-Sign pulse rate and ECG-derived pulse rate was
close to zero ()1.5% and +0.001 bpm, respectively), but
limits of agreement were unacceptably high ()21.4/
+18.4% and )22.3/+22.3 bpm). The best agreement was
found between transcutaneously measured values of the
Nellcor N-595 using a finger clip with SaO2 and ECG-
derived pulse rate (mean bias )0.07 % and )0.2 bpm;
limits of agreement )3.6/+3.4 % and )10.7/+11.1 bpm
[Table 2]). No patient showed any skin lesion or irritation
up to 6 h after removal of the sensor.
7.06.05.04.0
(PtcCO2 + PaCO2)/2
2.0
1.0
0.0
-1.0
2
OCaP
-2
OCctP
+2 SD
-2 SD
mean Bias
Fig. 1. Agreement between PtcCO2 and PaCO2 of 273 data pairs. Mean
bias +0.05 kPa; limits of agreement (LOA) )1.2/+1.3 kPa.
Table 2. Agreement between values of non-invasive measurements (V-sign, N-395 and N-595) and those of invasive measurements, using
Bland-Altman analysis
n Mean bias LOA
PtcCO2–PaCO2, kPa 273 +0.05 )1.2/+1.3
V-Sign SpO2–SaO2, % 327 )1.5 )21.4/+18.4
N-395 SpO2–SaO2, % 297 )2.8 )19/+13.4
N-595 SpO2–SaO2, % 309 )0.07 )3.6/+3.4
V-Sign PR – ECG, bpm 362 +0.001 )22.3/+22.3
N-395 PR – ECG, bpm 309 +0.56 )21.9/+33.2
N-595 PR – ECG, bpm 335 +0.17 )10.7/+11.1
Abbreviations: LOA, limits of agreement; PtcCO2, transcutaneous carbon dioxide tension; PaCO2, arterial carbon dioxide tension; V-Sign
SpO2, oxygen saturation measured with V-sign ear sensor; SaO2, arterial oxygen saturation; N-395 SpO2, oxygen saturation measured with
the ear sensor of Nellcor N-395 pulse oximeter; N-595 SpO2, oxygen saturation measured with the finger clip sensor of Nellcor N-595 pulse
oximeter; V-Sign PR, pulse rate measured with V-sign ear sensor; ECG, electrocardiography; N-395 PR, pulse rate measured with the ear
sensor of Nellcor N-395 pulse oximeter; N-595 PR, pulse rate measured with the finger clip sensor of Nellcor N-595 pulse oximeter.
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Fig. 2. PtcCO2 (solid line) and PaCO2 (dotted line) after calibration (cal),
during hypocapnia (hypo), normocapnia (normo), and hypercapnia (hyper),
and after 2 h, 4 h, 6 h and 8 h. Error bars: 95% confidence interval.
PtcCO2 shows an initial overshoot after calibration and a drift toward lower
values arising at the 4th hour of the study period.
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DISCUSSION
The main results of this study are (i) the accuracy of all
PtcCO2 values taken together was good, but the limits of
agreement were unacceptably high; (ii) first differences of
PtcCO2 and PaCO2 values were only moderately corre-
lated; (iii) the best agreement of PtcCO2 and PaCO2 was
found during normo- and hypoventilation; (iv) in the
majority of patients, an initial overshoot and/or a drift to
lower PtcCO2 values were observed, and calibration
failure of the V-Sign sensor occurred in 3 of 21 patients;
(v) SpO2 and pulse rate detection was poor.
Combined PtcCO2 and SpO2 monitors are noninvasive
devices using a single sensor mounted at the earlobe.
Rohling and Biro [15] investigated the Kontron device
(Kontron Monitor 7840 Kontron Instruments Medical
Sensors, Basel, Switzerland) in anaesthetized adult patients
and found good agreement between PtcCO2 and PaCO2
(mean bias )0.08 kPa; limits of agreement )0.38/
+0.22 kPa), and SpO2 values differed less than 1% from
those obtained by standard pulse oximetry. Dullenkopf
et al. [10] and Bernet-Buettiker et al. [9] validated the
TOSCA system (Linde Medical Sensors, Basel, Switzer-
land) in children and neonates, respectively. Both authors
reported a good agreement between PtcCO2 and PaCO2,
although their reported bias values differed significantly
()0.04 and +0.44, respectively). Whether this might be
explained by the different patient populations is unclear.
To our knowledge, only two reports validating the V-
Sign sensor against PaCO2 have so far been published [11,
13]. Kocher and coworkers [11] investigated the V-Sign
sensor in six adult volunteers during hypo- and hyper-
ventilation and reported excellent agreement between
PtcCO2 and PaCO2 (mean bias )0.024 kPa; limits of
agreement )0.31/+0.25 kPa). Recently, Rodriguez et al.
[13] tested the V-Sign sensor in 50 critically ill adult pa-
tients in a medical ICU. They excluded 21% of paired
PCO2 measurements; mean bias and limits of agreement
of the remaining PCO2 data pairs were )0.03 and )1.25/
+1.2 kPa, respectively.
The results of the present study correspond nicely to
those of Rodriguez et al. [13] in critically ill patients.
However, our data, as well as those of Rodriguez et al.
showed twofold to threefold-higher limits of agreement as
compared with the results of previous investigators [9–11,
15]. This difference might be explained in part by the fact
that we and Rodriguez et al. performed the investigations
in critically ill patients, whereas the other studies were
conducted in healthy volunteers [11], in ASA I/II adult
patients undergoing general anaesthesia [15] and in pae-
diatric patient populations [9, 10]. To what extent dif-
ferences in technical performance of the devices might
have contributed is unclear.
Using the SenTec V-Sign device, we observed two
technical problems with regard to the PtcCO2 signal, an
initial overshoot in 10 of our 18 patients, and a downward
drift with time in 15 patients (Figure 2). An initial over-
shoot of the PtcCO2 signal was previously reported by
Kagawa and coworkers [16] using the TOSCA device and
an ear probe heated to 42C in patients during abdominal
or thoracic surgery, 5–11 min after mounting the clip at
the ear. The observed difference between PtcCO2 and
PaCO2 disappeared after 25 min. In two volunteers, an
initial heating of the ear sensor to 45C for the first
15 min and then a decrease to 42C prevented the
overshoot and provided valid PtcCO2 values [16]. In
blood as well as in tissues, the temperature coefficient of
dissolved CO2 is 4.7% per degree centigrade. Like all
other PtcCO2 electrodes, the SenTec Digital Monitor V-
Sign sensor corrects for this temperature coefficient as well
as for an assumed diffusion gradient between epithelia and
capillaries within the skin and for the locally increased
metabolic rate. Normally, skin PCO2 is a function of
blood flow and metabolic rate and may be much higher
than PaCO2 when measured at 37C [17]. Early after
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Fig. 3. First differences of PtcCO2 and PaCO2 (R
2 = 0.377,
p < 0.001).
Table 3. Agreement between PtcCO2 and PaCO2 during various
states of ventilation using linear regression (r2) and Bland-Altman
analysis
State n r2 Mean bias (kPa) LOA (kPa)
Hypoventilation 36 0.59 +0.04 )0.81/+0.88
Hyperventilation 35 0.48 +0.28 )0.98/+1.54
Normoventilation 36 0.41 +0.02 )0.67/+0.69
Abbreviations: LOA, limits of agreement.
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cardiac surgery, mild residual hypothermia combined with
artificial heating of the earlobe may mobilize high tissue
CO2 that has accumulated before vasodilatation occurs.
Whether a short initial period of higher heating temper-
ature of the ear sensor may eliminate the overshoot, as
described by Kagawa and coworkers [16], needs further
investigation.
Looking at the different time periods of the PtcCO2
data acquisition, we found a drift of the initial calibration
value, the extent of which differed considerably between
patients, from 0.04 to 0.13 kPa/h. Although Rodriguez
et al. [13], using the same device, reported a good
agreement between PtcCO2 and PaCO2, the limits of
agreement they published were similar to ours. One
cannot exclude the possibility that they failed to recognize
this drifting problem. With other devices, lower limits of
agreement were reported [9, 10, 15]. Whether this might
be due to the absence of a PtcCO2 drift is unclear.
Similar to the observations of Kocher et al. [11] in six
volunteers, the data we obtained during normo- and
hypoventilation showed excellent accuracy of PtcCO2
monitoring and acceptable limits of agreement. The
agreement was less during hyperventilation, indicating a
detection problem at lower PCO2 values, which is
unexplained by the observed phenomena of overshoot
and drift.
Surprisingly, PtcCO2 did not correlate with cardiac
index values ranging between 1.5 and 5.2 liter/min/m2.
This lack of correlation, however, should be interpreted
with caution, because cardiac index was within normal
range for a patient population aged between 51 and
86 years of age. There were no signs of hypoperfusion
associated with organ dysfunction or metabolic distur-
bances. The decreasing difference between PtcCO2 and
PaCO2 with increasing body temperature can be
explained by an improvement of peripheral perfusion at
higher body temperatures.
PECO2 correlated well with PaCO2, but only mod-
erately well with PtcCO2, indicating that the PtcCO2
measured with the V-Sign sensor cannot be used as a
surrogate of PECO2.
Regarding pulse rate and SpO2, we observed better
robustness and fewer detection disturbances using the
V-Sign sensor as compared with the other devices, as
indicated by a higher detection rate (Table 2). Although
the detection of SpO2 and pulse rate was significantly
better with the V-Sign sensor, the limits of agreement
were unacceptably high. In contrast, Kocher and inves-
tigators [11] reported that both the Nellcor N-395 earlobe
sensor and the V-Sign sensor accurately tracked SpO2 and
pulse rate. However, their investigation was performed in
volunteers with presumably constant body temperature,
whereas our patients presented with initial hypothermia,
and their blood temperature increased with time. This
explanation is supported by the observation that the dif-
ferences between PtcCO2 and PaCO2 decreased at higher
body temperature. Interestingly, an excellent bias and very
low limits of agreement of SpO2 and SaO2, and of pulse
rate and ECG, were found with the Nellcor N-595 device
using the finger clip, whereas detection of both parame-
ters using the Nellcor N-395 earlobe sensor showed the
lowest agreement with the ECG-derived heart rate and
SaO2. These findings suggest that the location of the V-
Sign sensor at the ear lobe may not be the optimal place
for transcutaneous detection of oxygen saturation and
pulse rate in patients early after cardiac surgery.
In conclusion, the SenTec digital V-Sign device in its
present state of development has serious limitations. It will
be particularly important to improve the stability of the
calibration procedure for PtcCO2 and the reliability of
SpO2 and pulse rate detection. Varying interpretations of
previously published results may be explained by different
pretensions to accuracy.
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